2018
DOI: 10.1039/c7gc03469e
|View full text |Cite
|
Sign up to set email alerts
|

Catalytic hydrogenation of N-4-nitrophenyl nicotinamide in a micro-packed bed reactor

Abstract: Recent advancements in micro-flow technologies and a drive toward more efficient, greener and safer processes have led to a renaissance in flow-chemistry for pharmaceutical production.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
43
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 62 publications
(43 citation statements)
references
References 33 publications
0
43
0
Order By: Relevance
“…Traditionally kinetics are obtained in batch, which while having the advantage of providing multiple data points per experiment, may be limited by heat and mass transfer. In comparison, the development of flow microreactors with superior rates of heat and mass transport and improved safety [3][4][5][6][7] enable isothermal kinetic studies. 5,[8][9][10] Flow reactors are now often combined with online analysis to provide data-rich experimental platforms.…”
Section: Introductionmentioning
confidence: 99%
“…Traditionally kinetics are obtained in batch, which while having the advantage of providing multiple data points per experiment, may be limited by heat and mass transfer. In comparison, the development of flow microreactors with superior rates of heat and mass transport and improved safety [3][4][5][6][7] enable isothermal kinetic studies. 5,[8][9][10] Flow reactors are now often combined with online analysis to provide data-rich experimental platforms.…”
Section: Introductionmentioning
confidence: 99%
“…The residence time distribution or RTD is an important attribute in packed-bed reactors [13][14][15]. By the rule of thumb, the wider the column, and the poorer (i.e., the broader) is the RTD.…”
Section: Introductionmentioning
confidence: 99%
“…Among numerous pharmaceutical transformations, gas-liquid reactions, such as hydrogenation, 1 aerobic oxidation, 2,3 and ozonolysis, 4 show attractive atom economy in comparison to other chemical transformations. For example, direct hydrogenation of pharmaceutical precursors with hydrogen gas outpaces other costly sacrificial reducing reagents, such as hydrides (LiAlH 4 and NaBH 4 ) or borane reagents.…”
Section: Introductionmentioning
confidence: 99%
“…5 However, concerns of process efficiency, scalability, and safety of gas-liquid systems create barriers for pharmaceutical applications and this becomes even more challenging when heterogeneous catalysts are present in gas-liquid systems. 1,6 Over the past decade, continuous flow technology has emerged as a powerful technique to produce active pharmaceutical ingredients (APIs) driven by advantages of continuous technology over conventional batch or semi-batch processes, including steady state operation, enhanced heat and mass transfer rates, reproducibility, and improved safety and process reliability. [7][8][9][10][11][12] These benefits are especially true for gas-liquid reaction systems, where the absence of high-pressure headspace gas and reduced reactor volume of continuous flow reactors significantly improve the safety profiles compared to highpressure reaction vessels.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation